Brief: Resonance Specialties says no 483 observations issued in Mandideep site inspection by FDA
14/10/2016 11:21
Oct 14 (Reuters) - Resonance Specialties Ltd RESP.BO
* Resonance Specialties Ltd says Mandideep manufacturing
site inspected by the USFDA
* Resonance Specialties Ltd says no 483 observations have
been issued; EIR is awaited.
Source text - (http://bit.ly/2dgFsOA)
Further company coverage: RESP.BO
(Bengaluru newsroom)
((Reutersindia.snapping@thomsonreuters.com;))
Recent news on Resonance Specialties
See all newsBrief: Resonance Specialties Purchases Manufacturing Unit 299.8 Mln Rupees
Brief: Resonance Specialties Recommends Dividend Of 1 Rupee Per Share
Brief: Resonance Specialties Says Dividend Of 1 Rupee Per Share
Brief: Resonance Specialties CEO Ashish Katariya Resigns
Brief: Resonance Specialties Names Charchit Jain As CFO